| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |